Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
TBC CSL Behring Australia Pty Ltd
Product name
TBC
Sponsor
Accepted date
Jan-2024
Active ingredients
garadacimab
Proposed indication
Indicated for routine prevention of hereditary angioedema (HAE) attacks.
Application type
A (new medicine)
Publication date
Jan-2024
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.